Cargando…

A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting

Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited setting...

Descripción completa

Detalles Bibliográficos
Autores principales: Iddi, Shabani, Malindisa, Evangelista, Shija, Musa, Msemwa, Betrand, Silago, Vitus, Mirambo, Mariam, Mshana, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847209/
https://www.ncbi.nlm.nih.gov/pubmed/33552359
http://dx.doi.org/10.11604/pamj.2020.37.241.24234
_version_ 1783644886482812928
author Iddi, Shabani
Malindisa, Evangelista
Shija, Musa
Msemwa, Betrand
Silago, Vitus
Mirambo, Mariam
Mshana, Stephen
author_facet Iddi, Shabani
Malindisa, Evangelista
Shija, Musa
Msemwa, Betrand
Silago, Vitus
Mirambo, Mariam
Mshana, Stephen
author_sort Iddi, Shabani
collection PubMed
description Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited settings, some laboratory staff use different substitute buffers which has never been validated on their reliability. This study aimed at comparing the performance of 0.85% saline and SD-Bioline manufacturer´s buffer in detection of HIV antibodies. A total of 220 whole blood specimens: 110 HIV positive specimens from patients attending care and treatment center (CTC) and 110 HIV negative specimens from blood donors were re-tested for HIV status using SD-Bioline HIV rapid test using manufacturer´s buffer and 0.85% saline separately. Data and laboratory results were recorded in Microsoft excel sheet followed by analysis using STATA version 13. For all tested samples, the level of agreement between 0.85% saline and manufacturer´s buffer was 98.64% (kappa=0.9727). The value of kappa indicates very good agreement between 0.85% saline and manufacturer´s buffer. In incidents where manufacturer´s buffer is not sufficient, 0.85% saline can give reliable results. Further studies to evaluate the suitable buffer for other rapid tests for HIV and other diseases are recommended especially in resource limited settings.
format Online
Article
Text
id pubmed-7847209
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-78472092021-02-05 A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting Iddi, Shabani Malindisa, Evangelista Shija, Musa Msemwa, Betrand Silago, Vitus Mirambo, Mariam Mshana, Stephen Pan Afr Med J Short Communication Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited settings, some laboratory staff use different substitute buffers which has never been validated on their reliability. This study aimed at comparing the performance of 0.85% saline and SD-Bioline manufacturer´s buffer in detection of HIV antibodies. A total of 220 whole blood specimens: 110 HIV positive specimens from patients attending care and treatment center (CTC) and 110 HIV negative specimens from blood donors were re-tested for HIV status using SD-Bioline HIV rapid test using manufacturer´s buffer and 0.85% saline separately. Data and laboratory results were recorded in Microsoft excel sheet followed by analysis using STATA version 13. For all tested samples, the level of agreement between 0.85% saline and manufacturer´s buffer was 98.64% (kappa=0.9727). The value of kappa indicates very good agreement between 0.85% saline and manufacturer´s buffer. In incidents where manufacturer´s buffer is not sufficient, 0.85% saline can give reliable results. Further studies to evaluate the suitable buffer for other rapid tests for HIV and other diseases are recommended especially in resource limited settings. The African Field Epidemiology Network 2020-11-16 /pmc/articles/PMC7847209/ /pubmed/33552359 http://dx.doi.org/10.11604/pamj.2020.37.241.24234 Text en Copyright: Shabani Iddi et al. https://creativecommons.org/licenses/by/4.0 The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communication
Iddi, Shabani
Malindisa, Evangelista
Shija, Musa
Msemwa, Betrand
Silago, Vitus
Mirambo, Mariam
Mshana, Stephen
A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title_full A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title_fullStr A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title_full_unstemmed A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title_short A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting
title_sort 0.85% saline as alternative detection buffer for sd-bioline hiv rapid test in resource limited setting
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847209/
https://www.ncbi.nlm.nih.gov/pubmed/33552359
http://dx.doi.org/10.11604/pamj.2020.37.241.24234
work_keys_str_mv AT iddishabani a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT malindisaevangelista a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT shijamusa a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT msemwabetrand a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT silagovitus a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT mirambomariam a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT mshanastephen a085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT iddishabani 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT malindisaevangelista 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT shijamusa 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT msemwabetrand 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT silagovitus 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT mirambomariam 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting
AT mshanastephen 085salineasalternativedetectionbufferforsdbiolinehivrapidtestinresourcelimitedsetting